PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE FIRST QUARTER ENDED June 3, 2023GlobeNewsWire • 08/07/23
PetVivo Holdings, Inc. Achieves National Distribution of Spryng to More than 450 Veterinary ClinicsGlobeNewsWire • 07/20/23
PETVIVO HOLDINGS, INC. ANNOUNCES RESCHEDULED EARNINGS CALL FOR THE YEAR ENDED MARCH 31, 2023GlobeNewsWire • 06/29/23
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2023 ENDED MARCH 31, 2023GlobeNewsWire • 06/26/23
PetVivo Holdings, Inc. Begins Process to Pursue Approval of Biomatrix Particulate Technology for Initial Human IndicationGlobeNewsWire • 06/21/23
Dr. Thomas Yarbrough Joins PetVivo Holdings, Inc. as the Senior Research DirectorGlobeNewsWire • 06/05/23
Trina Lally Joins PetVivo Holdings, Inc. as the Northeast Business Development ManagerGlobeNewsWire • 05/17/23
PETVIVO HOLDINGS, INC. TO PRESENT AT AEGIS CAPITAL VIRTUAL CONFERENCE ON MAY 2-4, 2023GlobeNewsWire • 04/27/23
Mary Grace Rutland Joins PetVivo Holdings, Inc. as the Mid-Atlantic Business Development ManagerGlobeNewsWire • 04/25/23
Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Big Sky, MontanaGlobeNewsWire • 03/17/23
PetVivo Holdings, Inc. to Exhibit and Dr. Erik Kleeman of Ethos Veterinary Health to Present Canine Study Results at the Veterinary Orthopedic Society Annual ConferenceGlobeNewsWire • 03/10/23
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2022GlobeNewsWire • 02/02/23
PETVIVO HOLDINGS, INC. TO PARTICIPATE IN THE LYTHAM PARTNERS INVESTOR SELECT CONFERENCEGlobeNewsWire • 01/26/23
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE 44TH LAKE TAHOE EQUINE CONFERENCE IN INCLINE VILLAGE, NEVADAGlobeNewsWire • 01/23/23
PetVivo Holdings, Inc. to Present at Sequire Virtual Small Cap Conference on December 8th, 2022GlobeNewsWire • 12/05/22